Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mridushi Daga"'
Autor:
Frauke Muecksch, Zijun Wang, Alice Cho, Christian Gaebler, Tarek Ben Tanfous, Justin DaSilva, Eva Bednarski, Victor Ramos, Shuai Zong, Brianna Johnson, Raphael Raspe, Dennis Schaefer-Babajew, Irina Shimeliovich, Mridushi Daga, Kai-Hui Yao, Fabian Schmidt, Katrina G. Millard, Martina Turroja, Mila Jankovic, Thiago Y. Oliveira, Anna Gazumyan, Marina Caskey, Theodora Hatziioannou, Paul D. Bieniasz, Michel C. Nussenzweig
Publikováno v:
Nature. 607:128-134
The Omicron variant of SARS-CoV-2 infected many vaccinated and convalescent individuals1–3. Despite the reduced protection from infection, individuals who received three doses of an mRNA vaccine were highly protected from more serious consequences
Autor:
Pilar Mendoza, Frauke Muecksch, Katrina G. Millard, Melissa Cipolla, Fengwen Zhang, Victor A. Ramos, Paul D. Bieniasz, Juan Dizon, Justin DaSilva, Alice Cho, Michel C. Nussenzweig, Shlomo Finkin, Mila Jankovic, Martina Turroja, Thiago Y. Oliveria, Fabian Schmidt, Zijun Wang, Marina Caskey, Theodora Hatziioannou, Anna Gazumyan, Irina Shimeliovich, Eva Bednarski, Marianna Agudelo, Christian Gaebler, Mridushi Daga, Dennis Schaefer-Babajew, Tarek Ben Tanfous
Publikováno v:
Nature
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B cell responses that continue to evolve for at least a year. During that time, memory B cells express increasingly broad and potent antibodies that are resistant to muta
Autor:
Frauke, Muecksch, Zijun, Wang, Alice, Cho, Christian, Gaebler, Tarek Ben, Tanfous, Justin, DaSilva, Eva, Bednarski, Victor, Ramos, Shuai, Zong, Brianna, Johnson, Raphael, Raspe, Dennis, Schaefer-Babajew, Irina, Shimeliovich, Mridushi, Daga, Kai-Hui, Yao, Fabian, Schmidt, Katrina G, Millard, Martina, Turroja, Mila, Jankovic, Thiago Y, Oliveria, Anna, Gazumyan, Marina, Caskey, Theodora, Hatziioannou, Paul D, Bieniasz, Michel C, Nussenzweig
Publikováno v:
bioRxiv
The omicron variant of SARS-CoV-2 infected very large numbers of SARS-CoV-2 vaccinated and convalescent individuals1–3. The penetrance of this variant in the antigen experienced human population can be explained in part by the relatively low levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0eb6ea7c9fddfd55ae08c381da3a0a2
https://doi.org/10.1101/2022.02.14.480394
https://doi.org/10.1101/2022.02.14.480394
Autor:
Dennis Schaefer-Babajew, Frauke Muecksch, Mridushi Daga, Justin DaSilva, Mila Jankovic, Melissa Cipolla, Anna Gazumyan, Thiago Y. Oliveria, Martina Turroja, Marianna Agudelo, Tarek Ben Tanfous, Eva Bednarski, Pilar Mendoza, Katrina G. Millard, Michel C. Nussenzweig, Juan Dizon, Fengwen Zhang, Victor A. Ramos, Paul D. Bieniasz, Alice Cho, Shlomo Finkin, Fabian Schmidt, Zijun Wang, Marina Caskey, Irina Shimeliovich, Christian Gaebler, Theodora Hatziioannou
SummarySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B-cell responses that continue to evolve for at least one year. During that time, memory B cells express increasingly broad and potent antibodies that are resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b92c22ef7b933dddd252d0ee64823a6d
https://doi.org/10.1101/2021.07.29.454333
https://doi.org/10.1101/2021.07.29.454333
Autor:
Frauke Muecksch, Charlotte Viant, Thiago Y. Oliveira, Theodora Hatziioannou, Eva Bednarski, Charles M. Rice, Hans Heinrich Hoffmann, Anna Gazumyan, Justin Da Silva, Christian Gaebler, Christopher O. Barnes, Michel C. Nussenzweig, Melissa Cipolla, Shlomo Finkin, Katrina G. Millard, Lauren C. Aguado, Martina Turroja, Victor A. Ramos, Paul D. Bieniasz, Zhen Zhao, Fabian Schmidt, Mila Jankovic, Alice Cho, Jim Yee, Zijun Wang, Marina Caskey, Mridushi Daga, Dennis Schaefer-Babajew
Publikováno v:
Nature
More than one year after its inception, the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains difficult to control despite the availability of several working vaccines. Progres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b82b2b6bf9bd8f9fcf7226ca754bc2a7
https://resolver.caltech.edu/CaltechAUTHORS:20210510-104403619
https://resolver.caltech.edu/CaltechAUTHORS:20210510-104403619
Autor:
Frauke Muecksch, Charlotte Viant, Michel C. Nussenzweig, Thiago Y. Oliveira, Melissa Cipolla, Charles M. Rice, Martina Turroja, Zijun Wang, Marina Caskey, Mila Jankovic, Victor A. Ramos, Paul D. Bieniasz, Lauren C. Aguado, Eva Bednarski, Alice Cho, Shlomo Finkin, Zhen Zhao, Anna Gazumyan, Christopher O. Barnes, Katrina G. Millard, Fabian Schmidt, Christian Gaebler, Hans-Heinrich Hoffmann, Jim Yee, Mridushi Daga, Theodora Hatziioannou, Justin Da Silva, Dennis Schaefer-Babajew
Publikováno v:
bioRxiv
Over one year after its inception, the coronavirus disease-2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) remains difficult to control despite the availability of several excellent vaccines. Progress i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e202a2ed9da16fbbf2fc0b160dcd0740
https://doi.org/10.1101/2021.05.07.443175
https://doi.org/10.1101/2021.05.07.443175